4.6 Article

Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition

Journal

EXPERIMENTAL CELL RESEARCH
Volume 336, Issue 1, Pages 66-75

Publisher

ELSEVIER INC
DOI: 10.1016/j.yexcr.2015.03.023

Keywords

Hepatic stellate cells; TRPC6; Hypoxia; NICD

Funding

  1. Department of Biotechnology [BT/PR1440/AAQ/03/532/2010]

Ask authors/readers for more resources

Hepatic stellate cells (HSCs), a specialized stromal cytotype have a great impact on the biological behaviors of liver diseases. Despite this fact, the underlying mechanism that regulates HSC still remains poorly understood. The aim of the present study was to understand the role of TRPC6 signaling in regulating the molecular mechanism of HSCs in response to hypoxia. In the present study we showed that under hypoxia condition, the upregulated Hypoxia Inducible Factor 1 alpha (HIF1 alpha) increases NICD activation, which in turn induces the expression of transient receptor potential channel 6 (TRPC6) in HSC line lx-2. TRPC6 causes a sustained elevation of intracellular calcium which is coupled with the activation of the calcineurin-nuclear factor of activated T-cell (NFAT) pathway which activates the synthesis of extracellular matrix proteins. TRPC6 also activates SMAD2/3 dependent TGF-beta signaling in facilitating upregulated expression of alpha SMA and collagen. As activated HSCs may be a suitable target for HCC therapy and targeting these cells rather than the HCC cells may result in a greater response. Collectively, our studies indicate for the first time the detailed mechanism of activation of HSC through TRPC6 signaling and thus being a promising therapeutic target. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available